
Here we review the clinical data supporting these different plasma genotyping methodologies, and present a practical approach to the interpretation of the results of these tests.

Your AI-Trained Oncology Knowledge Connection!


Here we review the clinical data supporting these different plasma genotyping methodologies, and present a practical approach to the interpretation of the results of these tests.

Due to the delicate hemostatic balance in cancer patients, an understanding of both the clotting and bleeding risks in this population is crucial to effectively manage hematologic complications.

In this review, we discuss current management strategies, as well as future directions, for the management of uveal and conjunctival melanoma.

Published: October 15th 2016 | Updated:

Published: January 15th 2016 | Updated:

Published: August 15th 2017 | Updated: